DOCSLIB.ORG

The Use of Non-Human Primates in Research in Primates Non-Human of Use The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Use of Non-Human Primates in Research in Primates Non-Human of Use The The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations. The report is aimed at all those involved in non-human primate research, namely government, regulatory agencies, professional bodies, industry, research funders and the scientific community. For our part, we will consider and respond to its recommendations. We are grateful to the members of the working group for their considerable time and efforts in preparing this report. We especially thank Sir David Weatherall for leading on this important issue and producing a report that will be invaluable in taking forward this debate. Professor John Bell PMedSci Professor Colin Blakemore FRS FMedSci Academy of Medical Sciences Medical Research Council Lord Rees of Ludlow PRS Dr Mark Walport FMedSci The Royal Society Wellcome Trust Cover photograph reproduced with permission from the Wellcome Trust and the Medical Research Council CONTENTS Contents Abbreviations and acronyms 3 1 Summary 5 Recommendations 8 2 Introduction and methods of working 11 2. Background, objectives and timeliness 2.2 Scope and process of the report 4 3 Current position of non-human primate research 19 3. Introduction 9 3.2 A global overview 9 3.3 UK legal requirements 2 3.4 UK non-human primate use 24 3.5 Main fields of non-human primate research, excluding toxicology 3 3.6 Other uses of non-human primates 32 3.7 Discussion 32 4 Investigation into the scientific basis for current non-human primate research 35 4. Background 35 4.2 Why does the use of animals in biological and medical research vary so much between different fields? 35 4.3 Can research on humans replace work on non-human primates? 36 4.4 The distinction between basic and applied research 37 5 Infectious (communicable) disease 39 5. Introduction 39 5.2 HIV/AIDS 40 5.3 Malaria 47 5.4 Tuberculosis 50 5.5 Other infectious diseases 52 5.6 Discussion 56 6 Neuroscience 59 6. Introduction 59 6.2 Connectivity, neurons and circuits 60 6.3 Comparisons of vertebrate, non-human primate and human brains 62 6.4 Neuroscience research tools: direct and indirect techniques 64 6.5 Neuroscience research tools: observational and interventional techniques 67 6.6 The use of non-human primates in fundamental neuroscience research 68 6.7 The use of non-human primates in clinical neuroscience research 73 6.8 Brain-machine interfaces 8 6.9 Discussion 82 7 Other research areas 85 7. Introduction 85 7.2 Reproductive biology 85 The USE of Non-Human Primates in Research 7.3 Gender comparative studies relating to common human diseases 87 7.4 Fetal development and common disease in adult life 88 7.5 Ageing 89 7.6 Discussion 90 8 Drug discovery and development 91 8. Introduction 9 8.2 Regulations and regulatory agencies 9 8.3 Non-human primates and drug safety 9 8.4 Second species selection in regulatory toxicology 92 8.5 Non-human primates, regulatory toxicology and the 3Rs. 95 8.6 Discussion 97 9 Alternatives to the use of non-human primates for medical research and toxicology 99 9. Introduction 99 9.2 Molecular and cell biology approaches 99 9.3 Computer modelling and systems biology: in silico approaches 03 9.4 Human studies 04 9.5 Discussion 07 10 Welfare issues 109 0. Introduction 09 0.2 Breeding 0 0.3 Housing 2 0.4 Imported animals and transport 4 0.5 Welfare during the practice of research 5 0.6 Discussion 9 11 Ethics 123 . Introduction 23 .2 Moral status and legal personality 23 .3 Moral intuitions 24 .4 Costs and benefits 25 .5 Ethics and research involving non-human primates 26 .6 Discussion 29 12 Discussion 131 2. A polarised debate 3 2.2 The pace and unpredictability of biomedical research 3 2.3 A lack of integration in non-human primate research 3 2.4 The anecdotal nature of some of the issues in this report 32 2.5 The need for wider public debate 32 2.6 The future of UK non-human primate research 33 2.7 Future action based on this report 34 13 Conclusions and recommendations 135 Appendix I Report preparation 143 Appendix II List of consultees and respondents to the call for evidence 145 2 Abbreviations Abbreviations and acronyms 3Rs Replacement, Refinement and Reduction Ab Amyloid b protein ABPI Association of the British Pharmaceutical Industry AD Alzheimer’s disease ADME Absorption, Distribution, Metabolism and Excretion AIDS Acquired Immune Deficiency Syndrome AMS Accelerator Mass Spectrometry APC Animal Procedures Committee APP Amyloid Precursor Protein A(SP)A Animals (Scientific Procedures) Act 986 BBSRC Biotechnology and Biological Sciences Research Council BMI Brain-Machine Interface BOLD Blood Oxygen Level Dependent Activity BSE Bovine Spongiform Encephalopathy BUAV British Union for the Abolition of Vivisection CAT Computer Assisted Tomography CFM Centre for Macaques CITES Convention on International Trade in Endangered Species of Wild Fauna and Flora CNS Central Nervous System CSP Circumsporozoite protein CTL Cytotoxic T Lymphocyte DBS Deep Brain Stimulation Defra Department for Environment Food and Rural Affairs DNA Deoxyribonucleic Acid Dstl Defence Science and Technology Laboratory DTI Diffusion Tensor Imaging DWA Dangerous Wild Animals ECVAM European Centre for the Validation of Alternative Methods EEG Electroencephalogram EFPIA European Federation of Pharmaceutical Industries and Associations EMEA European Medicines Agency EPAA European Partnership on Alternative Approaches to Animal Testing ERP Ethical Review Process ES cells Embryonic Stem cells ESG Expert Scientific Group EU European Union EUMAPP European Union Microdose AMS Partnership Programme FDA US Food and Drug Administration fMRI Functional Magnetic Resonance Imaging GDNF Glial Cell Derived Neurotrophic Factor GM Genetically Modified HAART Highly Active Anti-Retroviral Therapy HBV Hepatitis B Virus HCV Hepatitis C Virus HIV Human Immunodeficiency Virus HO Home Office IAT Institute of Animal Technology 3 Non-HUman PriMATes in Medical Research IPS International Primate Society JALAS Japanese Association for Laboratory Animal Science LASA Laboratory Animals Science Association LGN Lateral Geniculate Nucleus MAbs Monoclonal Antibodies MCI Mild Cognitive Impairment MDR Multi-Drug Resistant MEG Magnetoencephalography MHC Major Histocompatibility Complex MHRA Medicines and Healthcare products Regulatory Agency MoD Ministry of Defence MPTP 1-methyl 4-phenyl ,2,3,6-tetrahydropyridine MRI Magnetic Resonance Imaging MS Multiple Sclerosis MTD Maximum Tolerated Dose MVA Modified vaccinia virus ankara NC3Rs National Centre for the Replacement, Refinement and Reduction of Animals in Research NFT Neurofibrillary Tangle NHP Non-human Primate OECD Organisation for Economic Co-operation and Development OHSS Ovarian Hyperstimulation Syndrome OPV Oral live poliovirus vaccine PCOS Polycystic ovarian syndrome PD Parkinson’s disease PET Positron Emission Tomography PPN Pedunculopontine Nucleus R&D Research and Development RNA Ribonucleic acid SARS Severe Acute Respiratory Syndrome SHIV Simian Human Immunodeficiency Virus SIV Simian Immunodeficiency Virus STAIR Stroke Therapy Academic Industry Roundtable STN Subthalamic Nucleus TB Tuberculosis TMS Transcranial Magnetic Brain Stimulation VEGF Vascular Endothelial Growth Factor WHO World Health Organization 4 SummarY Summary The central goal of this study was to examine ethical issues were considered. The members the scientific case for the use of non-human of the working group accepted a moral case primates for research into the prevention for careful, well monitored and meticulously or treatment of disease, or for fundamental regulated non-human primate research, research that has the long-term potential provided it is of a high quality and has the of achieving the same end. The material potential to benefit mankind, and if it is the presented in this report is primarily targeted only way of solving important scientific or at policy-makers in government, research medical questions. This does not preclude the funders, universities, scientific societies and need for consideration of ethics, together with relevant professional and regulatory bodies, scientific and welfare issues, in the cost-benefit as well as all other interested parties. It assessment of each research proposal. should be emphasised that its conclusions and recommendations reflect the views of the The total number of non-human primates members of the working group; the sponsors used for scientific or medical purposes in the played no part in determining its contents or in UK has remained fairly constant over the shaping its conclusions.
Load more

Recommended publications
  • 書 名 等 発行年 出版社 受賞年 備考 N1 Ueber Das Zustandekommen Der
    書 名 等 発行年 出版社 受賞年 備考 Ueber das Zustandekommen der Diphtherie-immunitat und der Tetanus-Immunitat bei thieren / Emil Adolf N1 1890 Georg thieme 1901 von Behring N2 Diphtherie und tetanus immunitaet / Emil Adolf von Behring und Kitasato 19-- [Akitomo Matsuki] 1901 Malarial fever its cause, prevention and treatment containing full details for the use of travellers, University press of N3 1902 1902 sportsmen, soldiers, and residents in malarious places / by Ronald Ross liverpool Ueber die Anwendung von concentrirten chemischen Lichtstrahlen in der Medicin / von Prof. Dr. Niels N4 1899 F.C.W.Vogel 1903 Ryberg Finsen Mit 4 Abbildungen und 2 Tafeln Twenty-five years of objective study of the higher nervous activity (behaviour) of animals / Ivan N5 Petrovitch Pavlov ; translated and edited by W. Horsley Gantt ; with the collaboration of G. Volborth ; and c1928 International Publishing 1904 an introduction by Walter B. Cannon Conditioned reflexes : an investigation of the physiological activity of the cerebral cortex / by Ivan Oxford University N6 1927 1904 Petrovitch Pavlov ; translated and edited by G.V. Anrep Press N7 Die Ätiologie und die Bekämpfung der Tuberkulose / Robert Koch ; eingeleitet von M. Kirchner 1912 J.A.Barth 1905 N8 Neue Darstellung vom histologischen Bau des Centralnervensystems / von Santiago Ramón y Cajal 1893 Veit 1906 Traité des fiévres palustres : avec la description des microbes du paludisme / par Charles Louis Alphonse N9 1884 Octave Doin 1907 Laveran N10 Embryologie des Scorpions / von Ilya Ilyich Mechnikov 1870 Wilhelm Engelmann 1908 Immunität bei Infektionskrankheiten / Ilya Ilyich Mechnikov ; einzig autorisierte übersetzung von Julius N11 1902 Gustav Fischer 1908 Meyer Die experimentelle Chemotherapie der Spirillosen : Syphilis, Rückfallfieber, Hühnerspirillose, Frambösie / N12 1910 J.Springer 1908 von Paul Ehrlich und S.
    [Show full text]
  • For European Biotech? Continued from Page 1 Around the World, Including the French Academies of Science by the Fact That the Complainants Did Not Challenge Them
    Competitive Enterprise Institute - Volume 19, Number 2 - March/April 2006 Neeww EEra,ra, oror ‘‘AncienAncien RRégime,’égime,’ fforor EEuropeanuropean BBiotech?iotech? by Gregory Conko he long-awaited World Trade all remain in effect argues in favor of Organization (WTO) decision intervention by the WTO. (Ironically, Ton biotech food is due to be the current WTO Director General is released this spring, but a leaked copy none other than Pascal Lamy.) of the report has already elicited The most important victory for the considerable buzz. Most United States and its partners is the analyses score it a resounding WTO’s judgment that the EU failed to victory for the United States abide by its own regulations by “unduly and its co-complainants, and a delaying” fi nal approval of otherwise stinging defeat for European state complete applications for 25 food biotech protectionism. When it came time for products. The culprit here is the European The reality is that the decision their WTO defense, Commission’s highly politicized, two-stage is only a partial and largely symbolic however, the Europeans approval process: Each application must victory. For not achieving a more complete actually denied that a moratorium had ever fi rst be cleared for marketing by various and meaningful success, the United States, existed. Fortunately, the WTO decision scientifi c panels, and then voted on by Canada, and Argentina, which jointly fi led acknowledges the EU’s illegal practices— elected politicians. the complaint, have their own excessively and the disingenuousness of the EU’s Signifi cantly, the WTO assumed that risk-averse policies to blame.
    [Show full text]
  • The Use of Non-Human Primates in Research in Primates Non-Human of Use The
    The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations.
    [Show full text]
  • Animal People News
    European Commission votes to ban dog &cat fur B R U S S E L S ––The European Commis- sion on November 20 adopted a proposal to ban the import, export, and sale of cat and dog fur throughout the European Union. “The draft regulation will now be considered by the European Parliament and the Council of Ministers for adoption by the co- decision procedure,” explained the EC Asian dog. (Kim Bartlett) announcement. “There is evidence that cat and dog fur been found not just on clothing, but also on a is being placed on the European market, usually number of personal accessories, as well as chil- dren’s soft toys.” Asian rabbits. (Kim Bartlett) undeclared as such or disguised as synthetic and other types of fur,” the EC announcement sum- “Just the idea of young children playing marized. “The vast majority of the cat and dog with toys which have been made with dog and Olympics to showcase growing fur is believed to be imported from third coun- cat fur is really something we cannot accept,” tries, notably China.” European Consumer Protection Commissioner Fifteen of the 25 EU member nations Markos Kyprianou said. Chinese animal testing industry have already individually introduced legislation “Kyprianou stopped short of calling B E I J I N G ––The 2008 Olympic Glenn Rice, chief executive of Bridge against cat and dog fur. “The proposed regula- for every product containing fur to have a label Games in Beijing will showcase the fast- Pharmaceuticals Inc., is outsourcing the tion adopted today addresses EU citizens con- detailing its exact origin,” wrote London Times growing Chinese animal testing industry, work to China, where scientists are cheap cerns, and creates a harmonized approach,” the European correspondent David Charter, the official Xinhua news agency disclosed and plentiful and animal-rights activists are EC announcement stipulated.
    [Show full text]
  • Animal Research Essay Resources 2013
    Animal research essay resources 2013 Animal Research Essay Resources (Manage) and AO2 (Use Resources) assessment objectives of their EPQ. Click on one of the links below for resources on the specific area of interest surrounding the AO1 requires students to identify their topic and issue of animal testing: the project’s aims and objectives. They must then produce a project plan and complete their History of animal research work, applying organisational skills and Ethics of animal experiments strategies to meet stated objectives. This page Costs and benefits of research aims to help students get a handle on the topic Regulatory systems and the 3Rs of animal research and provide some inspiration Animal rights activism and extremism for possible areas of further study. General Websites AO2 requires students to obtain, and select Many students, from primary school to from, a variety of resources, analyse and apply university, write assignments that relate to the this data in a relevant manner and demonstrate issue of animal research. This page aims to an understanding of appropriate links. This page support this by providing links to useful will provide links to large amounts of relevant materials. It is especially useful to any students information that students can use for their carrying out the Extended Project Qualification project, however it remains up to students to (EPQ) alongside their A-levels or Extended Essay critically analyse and apply it to their specific as part of their International Baccalaureate project focus. studies. Those students should read the section below. History of animal research Beneath each link is a Harvard Reference for the The use of animals in scientific experiments in book, webpage or document in question which the UK can be traced back at least as far as the can be used in the footnotes or endnotes of 17th Century with Harvey’s experiments on your project paper.
    [Show full text]
  • Reporting the Implementation of the Three Rs in European Primate and Mouse Research Papers: Are We Making Progress?
    ATLA 38, 495–517, 2010 495 Reporting the Implementation of the Three Rs in European Primate and Mouse Research Papers: Are We Making Progress? Katy Taylor British Union for the Abolition of Vivisection, London, UK Summary — It is now more than 20 years since both Council of Europe Convention ETS123 and EU Directive 86/609?EEC were introduced, to promote the implementation of the Three Rs in animal experi- mentation and to provide guidance on animal housing and care. It might therefore be expected that reports of the implementation of the Three Rs in animal research papers would have increased during this period. In order to test this hypothesis, a literature survey of animal-based research was conducted. A ran- domly-selected sample from 16 high-profile medical journals, of original research papers arising from European institutions that featured experiments which involved either mice or primates, were identified for the years 1986 and 2006 (Total sample = 250 papers). Each paper was scored out of 10 for the incidence of reporting on the implementation of Three Rs-related factors corresponding to Replacement (justification of non-use of non-animal methods), Reduction (statistical analysis of the number of animals needed) and Refinement (housing aspects, i.e. increased cage size, social housing, enrichment of cage environment and food; and procedural aspects, i.e. the use of anaesthesia, analgesia, humane endpoints, and training for procedures with positive reinforcement). There was no significant increase in overall reporting score over time, for either mouse or primate research. By 2006, mouse research papers scored an average of 0 out of a possible 10, and primate research papers scored an average of 1.5.
    [Show full text]
  • In Pursuit of an HIV Vaccine: an Interview with Andrew Mcmichael Andrew J Mcmichael
    McMichael BMC Biology 2013, 11:60 http://www.biomedcentral.com/1741-7007/11/60 INTERVIEW Open Access In pursuit of an HIV vaccine: an interview with Andrew McMichael Andrew J McMichael Andrew McMichael qualified in Medicine before doing a PhD in Immunology with Ita Askonas and Alan Williamson in the 1970s. His research during this time and later work done in his group has made a major contri- bution to our understanding of T-cell-mediated immunity against viral infections. Initially he worked on the immune response to influenza, but latterly studying the T cell re- sponse against HIV has been a major focus, and his group has designed and tested two candidate HIV vaccines in phase I clinical trials. Based through most of his research career in Oxford, he was knighted in 2008 for services to medical sciences, and has just completed 12 years as Director of the Weatherall Institute of Molecular Medicine. In this 30th year since the discovery of HIV as the cause of AIDS, we asked Sir Andrew to give us his per- sonal perspective on the progress towards a vaccine. Andrew J McMichael Would you like to start by telling us how and when you first started working on HIV? working on immune responses to HIV. A lot of virolo- We started in 1986 or 1987 when my laboratory was fo- gists were already working on it of course. So we cused on studying immune responses to influenza. I actu- thought we’d start on it in quite a small way, but realiz- ally had a clinical training fellow - Douglas Nixon - who ing that if the experiments worked, it would probably was studying to be a clinical virologist.
    [Show full text]
  • Non-Human Primates in Biomedical Research
    Science Shop for Biology Non-human primates in biomedical research Frouke Pieters P-UB-2006-06 Non-human primates in biomedical research Reasons and alternatives for their use Frouke Pieters Science shop for Biology Netherlands Centre Alternatives to Animal Use, Utrecht University, The Netherlands April 2007 P-UB-2006-06 Colofon Report number P-UB-2006-06 ISBN 978-90-5209-158-7 Price € 5,- Publication date April 2007 Edition First Title Non-human primates in biomedical research Reasons and alternatives for their use Author Frouke Pieters Supervisor Prof. Dr. C. Hendriksen, Netherlands Centre Alternatives to animal use, Utrecht University, The Netherlands Project coordinator Ir. M. A. Vaal, Science Shop for Biology, Utrecht University Commissioned by Working party 'Primate Research in the Netherlands' under the auspices of the Dutch Association for Laboratory Animal Science, Amsterdam Reproduction Document Diensten Centrum Uithof Publisher Science shop for Biology, Utrecht University Padualaan 8, 3584 CH Utrecht, The Netherlands. .. 31 30 253 7363 www.bio.uu.nl/scienceshop Copyright This document (or parts thereof) may not be multiplied in any form. Parts of the document may be used for other publications, if a reference is included. Contents Preface 5 Summary 7 Samenvatting 8 1 Introduction 9 1.1 Motivation 9 1.2 Definition of the problem 10 1.3 Scope and definitions 10 1.4 Approach 11 1.5 Structure 12 2 Use of primates 13 2.1 Figures 13 2.2 Goals of primate studies 18 2.3 Regulations on animal experimentation 21 2.4 Ethics 22 2.5 Problems
    [Show full text]
  • Medical Research Council Annual Report and Accounts 2006/07 HC 93
    06/07 Annual Report and Accounts © Crown Copyright 2006 The text in this document (excluding any Royal Arms and departmental logos) may be reproduced free of charge in any format or medium providing that it is reproduced accurately and not used in a misleading context. The material must be acknowledged as Crown copyright and the title of the document specified. Any queries relating to the copyright in this document should be addressed to The Licensing Division, HMSO, St Clements House, 2-16 Colegate, Norwich, NR3 1BQ. Fax: 01603 723000 or e-mail: licensing@cabinet-office.x.gsi.gov.uk 2 MRC Annual Report and Accounts 2006/07 Medical Research Council Annual Report and Accounts 2006/07 Presented to Parliament by the Secretary of State, and by the Comptroller and Auditor General in pursuance of Schedule I, Sections 2(2) and 3(3) of the Science and Technology Act 1965. Sir John Chisholm Chairman Professor Sir Leszek Borysiewicz Deputy Chairman and Chief Executive Ordered by and printed on London: The Stationery Office 6 February 2008 Price: £18.55 HC 93 The Medical Research Council The MRC RCUK The Medical Research Council (MRC) was set up in 1913 to administer Research Councils UK (RCUK) is a partnership of the seven (formerly public funds for medical research. It was incorporated under its eight) UK Research Councils – public bodies funded mainly by the UK present title by Royal Charter in 1920. A supplemental charter was Government via OSI. granted in 1993 describing the MRC’s new mission following the 1993 government white paper on science and technology.
    [Show full text]
  • Harnessing Opportunities in Non-Animal Asthma Research for a 21St-Century Science
    WellBeing International WBI Studies Repository 11-2011 Harnessing Opportunities in Non-Animal Asthma Research for a 21st-Century Science Gemma L. Buckland Humane Society International Follow this and additional works at: https://www.wellbeingintlstudiesrepository.org/acwp_arte Part of the Bioethics and Medical Ethics Commons, Laboratory and Basic Science Research Commons, and the Research Methods in Life Sciences Commons Recommended Citation Buckland, G. L. (2011). Harnessing opportunities in non-animal asthma research for a 21st-century science. Drug discovery today, 16(21), 914-927. This material is brought to you for free and open access by WellBeing International. It has been accepted for inclusion by an authorized administrator of the WBI Studies Repository. For more information, please contact [email protected]. Harnessing opportunities in non-animal asthma research for a 21st-century science Gemma L. Buckland, Humane Society International CITATION Buckland, G. L. (2011). Harnessing opportunities in non-animal asthma research for a 21st-century science. Drug discovery today, 16(21), 914-927. ABSTRACT The incidence of asthma is on the increase and calls for research are growing, yet asthma is a disease that scientists are still trying to come to grips with. Asthma research has relied heavily on animal use; however, in light of increasingly robust in vitro and computational models and the need to more fully incorporate the ‘Three Rs’ principles of Replacement, Reduction and Refinement, is it time to reassess the asthma research paradigm? Progress in non-animal research techniques is reaching a level where commitment and integration are necessary. Many scientists believe that progress in this field rests on linking disciplines to make research directly translatable from the bench to the clinic; a ‘21st-century’ scientific approach to address age-old questions.
    [Show full text]
  • JUAN MANUEL 2016 NOBEL PEACE PRIZE RECIPIENT Culture Friendship Justice
    Friendship Volume 135, № 1 Character Culture JUAN MANUEL SANTOS 2016 NOBEL PEACE PRIZE RECIPIENT Justice LETTER FROM THE PRESIDENT Dear Brothers, It is an honor and a privilege as your president to have the challenges us and, perhaps, makes us question our own opportunity to share my message with you in each edition strongly held beliefs. But it also serves to open our minds of the Quarterly. I generally try to align my comments and our hearts to our fellow neighbor. It has to start with specific items highlighted in each publication. This with a desire to listen, to understand, and to be tolerant time, however, I want to return to the theme “living our of different points of view and a desire to be reasonable, Principles,” which I touched upon in a previous article. As patient and respectful.” you may recall, I attempted to outline and describe how Kelly concludes that it is the diversity of Southwest’s utilization of the Four Founding Principles could help people and “treating others like you would want to be undergraduates make good decisions and build better treated” that has made the organization successful. In a men. It occurred to me that the application of our values similar way, Stephen Covey’s widely read “Seven Habits of to undergraduates only is too limiting. These Principles are Highly Effective People” takes a “values-based” approach to indeed critical for each of us at this particularly turbulent organizational success. time in our society. For DU to be a successful organization, we too, must As I was flying back recently from the Delta Upsilon be able to work effectively with our varied constituents: International Fraternity Board of Directors meeting in undergraduates, parents, alumni, higher education Arizona, I glanced through the February 2017 edition professionals, etc.
    [Show full text]
  • Environmental Enrichment for Nonhuman Primates Resource Guide [Electronic Resource] AWIC Resource Series No
    United States Department of Agriculture Environmental Enrichment Agricultural Research Service for Nonhuman Primates National Agricultural Library Resource Guide Animal Welfare Information Center 2006 (Updated October 2009) Photo courtesy Photos8.com AWIC Resource Series No. 32 United States Department of Environmental Agriculture Enrichment for Agricultural Research Service Nonhuman Primates National Agricultural Resource Guide Library AWIC Resource Series No. 32 Animal Welfare Information Center 2006 (Updated October 2009) Compiled by: Kristina M. Adams, M.S. Animal Welfare Information Center National Agricultural Library U.S. Department of Agriculture Beltsville, Maryland 20705 E-mail: [email protected] Web site: http://awic.nal.usda.gov Available online: http://www.nal.usda.gov/awic/pubs/Primates2009/primates.shtml National Agricultural Library Cataloging Record Adams, Kristina M. Environmental Enrichment for Nonhuman Primates Resource Guide [electronic resource] AWIC Resource Series No. 32, Updated 1. Environmental enrichment (Animal culture) -- Bibliography. 2. Primates -- Environmental Enrichment -- Bibliography. I. Animal Welfare Information Center (U.S.) II. Title. aHV4701 .A94 no. 32, Updated Disclaimers The U.S. Department of Agriculture (USDA) prohibits discrimination in all its programs and activities on the basis of race, color, national origin, age, disability, and where applicable, sex, marital status, familial status, parental status, religion, sexual orientation, genetic information, political beliefs, reprisal, or because all or a part of an individual’s income is derived from any public assistance program. (Not all prohibited bases apply to all programs.) Persons with disabilities who require alternative means for communication of program information (Braille, large print, audiotape, etc.) should contact USDA’s TARGET Center at (202) 720-2600 (voice and TDD).
    [Show full text]